Purpose: This study aimed to explore the complication rates of radical cystectomy in patients with muscle-invasive bladder cancer and identify potential risk factors. Methods: A total of 553 patients were included: 131 were operated on via an open approach (ORC), 242 patients via a laparoscopic method (LRC), and 180 by a robot-assisted procedure (RARC). Patient age, gender, American Society of Anesthesiologists (ASA) score, urinary diversion type, preoperative albumin level, body mass index (BMI), pathological (TNM) stage, and surgical times were collected. The severity of complications was classified according to the Clavien-Dindo scale (Grades 1–5). Results: The surgical technique was significantly related to the number of complications (p < 0.00005). Grade 1 complications were observed most frequently following LRC (52.5%) and RARC (51.1%), whereas mostly Grade 2 complications were detected after ORC (78.6%). Those with less severe complications had significantly higher albumin levels than those with more severe complications (p < 0.05). Patients with an elevated BMI had fewer complications if a minimally invasive approach was used rather than ORC. The patient’s general condition (ASA score) did not impact the number of complications, and urinary diversion type did not affect the severity of the complications. Mean surgical time differed according to the urinary diversion type in patients with a similar TNM stage (p < 0.005); however, no difference was found in those with more locally advanced disease. Longer operation time and lower protein concentration were associated with higher probability of complication rate, that is, Clavien-Dindo score 3–5. Conclusions: The risk of complications after RC is not related to the type of urinary diversion, and can be reduced by using a minimally invasive surgical technique, especially in patients with high BMI.

1.
Siegel
RL
,
Miller
KD
,
Jemal
A
.
Cancer statistics, 2018
.
CA Cancer J Clin
.
2018
;
68
:
7
30
. .
2.
Stein
JP
,
Lieskovsky
G
,
Cote
R
,
Groshen
S
,
Feng
A-C
,
Boyd
S
,
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients
.
J Clin Oncol
.
2001
;
19
(
3
):
666
75
. .
3.
Boström
PJ
,
Kössi
J
,
Laato
M
,
Nurmi
M
.
Risk factors for mortality and morbidity related to radical cystectomy
.
BJU Int
.
2009
;
103
(
2
):
191
6
. .
4.
Lowrance
WT
,
Rumohr
JA
,
Chang
SS
,
Clark
PE
,
Smith
JA
,
Cookson
MS
.
Contemporary open radical cystectomy: analysis of perioperative outcomes
.
J Urol
.
2008
;
179
(
4
):
1313
8
. .
5.
Sánchez de Badajoz
E
,
Gallego Perales
JL
,
Reche Rosado
A
,
Gutiérrez de la Cruz
JM
,
Jiménez Garrido
A
.
Radical cystectomy and laparoscopic ileal conduit
.
Arch Esp Urol
.
1993
;
46
:
621
4
.
6.
Guillotreau
J
,
Gamé
X
,
Mouzin
M
,
Doumerc
N
,
Mallet
R
,
Sallusto
F
,
Radical cystectomy for bladder cancer: morbidity of laparoscopic versus open surgery
.
J Urol
.
2009
;
181
(
2
):
554
9
. .
7.
Menon
M
,
Hemal
AK
,
Tewari
A
,
Shrivastava
A
,
Shoma
AM
,
El-Tabey
NA
,
Nerve-sparing robot-assisted radical cystoprostatectomy and urinary diversion
.
BJU Int
.
2003
;
92
(
3
):
232
6
. .
8.
Clavien
PA
,
Barkun
J
,
de Oliveira
ML
,
Vauthey
JN
,
Dindo
D
,
Schulick
RD
,
The Clavien-Dindo classification of surgical complications: five-year experience
.
Ann Surg
.
2009
;
250
(
2
):
187
96
. .
9.
Xia
L
,
Wang
X
,
Xu
T
,
Zhang
X
,
Zhu
Z
,
Qin
L
,
Robotic versus open radical cystectomy: an updated systematic review and meta-analysis
.
PLoS One
.
2015
;
10
(
3
):
e0121032
. .
10.
Hautmann
RE
,
de Petriconi
RC
,
Pfeiffer
C
,
Volkmer
BG
.
Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients
.
Eur Urol
.
2012
;
61
(
5
):
1039
47
. .
11.
Hautmann
RE
,
de Petriconi
RC
,
Volkmer
BG
.
Lessons learned from 1,000 neobladders: the 90-day complication rate
.
J Urol
.
2010
;
184
(
3
):
990
1235
. .
12.
Garg
T
,
Chen
LY
,
Kim
PH
,
Zhao
PT
,
Herr
HW
,
Donat
SM
.
Preoperative serum albumin is associated with mortality and complications after radical cystectomy
.
BJU Int
.
2014
;
113
(
6
):
918
23
. .
13.
Karl
A
,
Staehler
M
,
Bauer
R
,
Tritschler
S
,
Hocaoglu
Y
,
Buchner
A
,
Malnutrition and clinical outcome in urological patients
.
Eur J Med Res
.
2011
;
16
(
10
):
469
72
. .
14.
Witjes
JA
,
Bruins
M
,
Cathomas
R
,
Compérat
E
,
Cowan
NC
,
Efstathiou
JA
,
EAU guidelines on muscle-invasive and metastatic bladder cancer
.
EAU Guidelines Office
. Available from: https://uroweb.org/guideline/bladder-cancer-muscle-invasive-and-metastatic/2019.
15.
McDougal
WS
,
Wein
AJ
,
Kavoussi
LR
,
Novick
AC
,
Partin
AW
,
Peters
CA
,
Campbell-Walsh urology
. 10th ed.
Saunders
;
2011
.
16.
Sobin
LH
,
Wittekind
C
.
TNM classification of malignant tumours
. 6th ed.
New York
:
Wiley-Blackwell
;
2002
. p.
23
5
.
17.
Doyle
DJ
,
Goyal
A
,
Bansai
P
,
Garmon
EH
.
American Society of Anesthesiologists Classification (ASA Class)
StatPearls Publishing
;
2020
.
18.
Shabsigh
A
,
Korets
R
,
Vora
KC
,
Brooks
CM
,
Cronin
AM
,
Savage
C
,
Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology
.
Eur Urol
.
2009
;
55
(
1
):
164
74
. .
19.
Sathianathen
NJ
,
Kalapara
A
,
Frydenberg
M
,
Lawrentschuk
N
,
Weight
CJ
,
Parekh
D
,
Robotic assisted radical cystectomy vs open radical cystectomy: systematic review and meta-analysis
.
J Urol
.
2019
;
201
(
4
):
715
20
. .
20.
Prcic
A
,
Begic
E
.
Complications after ileal urinary derivations
.
Med Arch
.
2017
;
71
(
5
):
320
4
. .
21.
Gregg
JR
,
Cookson
MS
,
Phillips
S
,
Salem
S
,
Chang
SS
,
Clark
PE
,
Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer
.
J Urol
.
2011
;
185
(
1
):
90
6
. .
22.
Lambert
JW
,
Ingham
M
,
Gibbs
BB
,
Given
RW
,
Lance
RS
,
Riggs
SB
.
Using preoperative albumin levels as a surrogate marker for outcomes after radical cystectomy for bladder cancer
.
Urology
.
2013
;
81
(
3
):
587
92
. .
23.
Djaladat
H
,
Bruins
HM
,
Miranda
G
,
Cai
J
,
Skinner
EC
,
Daneshmand
S
.
The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer
.
BJU Int
.
2014
;
113
(
6
):
887
93
. .
24.
Chang
SS
,
Jacobs
B
,
Wells
N
,
Smith
JA
,
Cookson
MS
.
Increased body mass index predicts increased blood loss during radical cystectomy
.
J Urol
.
2004
;
171
(
3
):
1077
9
. .
25.
Hughes
TM
,
Shah
K
,
Noria
S
,
Pawlik
T
.
Is BMI associated with post-operative complication risk among patients undergoing major abdominal surgery for cancer? A systematic review
.
J Surg Oncol
.
2018
;
117
(
5
):
1009
19
. .
26.
Toma
O
,
Suntrup
P
,
Stefanescu
A
,
London
A
,
Mutch
M
,
Kharasch
E
.
Pharmacokinetics and tissue penetration of cefoxitin in obesity: implications for risk of surgical site infection
.
Anesth Analg
.
2011
;
113
(
4
):
730
7
. .
27.
Herr
H
,
Lee
C
,
Chang
S
,
Lerner
S
.
Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report
.
J Urol
.
2004
;
171
(
5
):
1823
8
. .
28.
Adamczyk
P
,
Juszczak
K
,
Kadłubowski
M
,
Ostrowski
A
,
Maciukiewicz
P
,
Drewa
T
.
Can laparoscopic cystectomy become the method of choice in the treatment of invasive urothelial urinary bladder cancer?
Adv Clin Exp Med
.
2020
;
29
(
3
):
301
6
. .
29.
Linder
BJ
,
Frank
I
,
Cheville
JC
,
Tollefson
MK
,
Thompson
RH
,
Tarrell
RF
,
The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy
.
Eur Urol
.
2013
;
63
(
5
):
839
45
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.